![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/GUJTHEM.png)
Share the post "GUJARAT THEMIS BIOSYN ‘s Q3 2024-25 Latest News: Profit Falls by 0.31% Year-on-Year"
Highlights
🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 1.7 % in the past year, substantial increase in net sales/revenue by 13.83 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -75.9 %, Marginal decrease of -24.14% in other income during this quarter. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for GUJARAT THEMIS BIOSYN LTD.. Profit dropped by -0.32 % Year to Year, GUJARAT THEMIS BIOSYN LTD.’s profitability increased by 22.76 % in this quarter. 🔹 EPS over the Year and quarter: EPS declined by -33.52 % Year to Year. EPS increased by 22.68 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 38.859 Cr | Rs. 34.717 Cr | Rs. 39.52 Cr | + 13.83 % | + 1.7 % |
| Expenses | Rs. 21.11 Cr | Rs. 19.33 Cr | Rs. 20.65 Cr | + 6.83 % | -2.18 % |
| Operating Profit | Rs. 17.75 Cr | Rs. 15.39 Cr | Rs. 18.87 Cr | + 22.61 % | + 6.31 % |
| OPM % | 45.68 % | 44.33 % | 47.75 % | + 3.42 % | + 2.07 % |
| Other Income | Rs. 1.004 Cr | Rs. 0.319 Cr | Rs. 0.242 Cr | -24.14 % | -75.9 % |
| Interest | Rs. 0.08 Cr | Rs. 0.08 Cr | Rs. 0.15 Cr | + 87.5 % | + 87.5 % |
| Depreciation | Rs. 0.98 Cr | Rs. 1.44 Cr | Rs. 1.56 Cr | + 8.33 % | + 59.18 % |
| Profit before tax | Rs. 17.69 Cr | Rs. 14.19 Cr | Rs. 17.4 Cr | + 22.62 % | -1.64 % |
| Tax % | 26.45 % | 25.54 % | 25.45 % | -0.09 % | -1 % |
| Net Profit | Rs. 13.01 Cr | Rs. 10.57 Cr | Rs. 12.97 Cr | + 22.71 % | -0.31 % |
| EPS in Rs | Rs. 1.79 | Rs. 0.97 | Rs. 1.19 | + 22.68 % | -33.52 % |
Today, we’re looking at GUJARAT THEMIS BIOSYN LTD.’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 1.7 %. However, it did see a marginal increase of 13.83 % from the previous quarter. Expenses ticked up slightly by 6.83 % quarter-on-quarter, aligning with the annual decline of -2.18 %. Operating profit, while up 6.31 % compared to last year, faced a quarter-on-quarter increase of 22.61 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.07 %, but an expansion of 3.42 % sequentially. Other income fell by -24.14 % compared to the last quarter, despite an annual decline of -75.9 %. Interest expenses surged remarkably by 87.5 % from the previous quarter, yet the year-over-year increase remains at a moderate 87.5 %. Depreciation costs climbed by 8.33 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 59.18 %. Profit before tax declined annually by -1.64 % but saw an increase from the preceding quarter by 22.62 %.
Tax expenses as a percentage of profits decreased slightly by -1 % compared to last year, with a more notable quarter-on-quarter decrease of -0.09 %. Net profit fell by -0.31 % year-on-year but experienced a 22.71 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -33.52 % but a quarterly rise of 22.68 %. In summary, GUJARAT THEMIS BIOSYN LTD.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 38.859 Cr | Rs. 34.717 Cr | Rs. 39.52 Cr | + 13.83 % | + 1.7 % |
| Expenses | Rs. 21.11 Cr | Rs. 19.33 Cr | Rs. 20.65 Cr | + 6.83 % | -2.18 % |
| Operating Profit | Rs. 17.75 Cr | Rs. 15.39 Cr | Rs. 18.87 Cr | + 22.61 % | + 6.31 % |
| Net Profit | Rs. 13.01 Cr | Rs. 10.57 Cr | Rs. 12.97 Cr | + 22.71 % | -0.31 % |
| EPS in Rs | Rs. 1.79 | Rs. 0.97 | Rs. 1.19 | + 22.68 % | -33.52 % |
In reviewing GUJARAT THEMIS BIOSYN LTD.’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 1.7 % year-on-year growth, however, there was a minor increase of 13.83 % from the previous quarter. Expenses decreased by -2.18 % compared to the previous year, with a 6.83 % increase quarter-on-quarter. Operating Profit surged by 6.31 % annually, and saw a 22.61 % increase from the last quarter.
Net Profit showed yearly decrease of -0.31 %, and experienced a 22.71 % increase from the previous quarter. Earnings Per Share (EPS) fell by -33.52 % annually, however rose by 22.68 % compared to the last quarter. In essence, while GUJARAT THEMIS BIOSYN LTD. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/TITAN.png)
